Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion type Assertion NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_head.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_provenance.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion evidence source_evidence_literature NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_provenance.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion SIO_000772 21325603 NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_provenance.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion wasDerivedFrom befree-20140225 NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_provenance.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion wasGeneratedBy ECO_0000203 NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_provenance.